CHRN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $19.21
Market Cap (MRQ) $2.79B
P/E -53.4
EPS $-0.36
Revenue $72M
ROE -53.2%
Debt/Equity 0.0
52W Range $12–$30

CHRN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 3
Ex-date Split Type
June 2, 2025 1-for-15 Reverse
March 25, 2020 1-for-15 Reverse
May 5, 2016 1-for-7 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$72M
2025-05-31 → 2026-05-31
EPS$-0.36
2025-05-31 → 2026-05-31
Free Cash Flow$12M
2026-05-31 → 2026-05-31
Net margin-70.3%
2026-05-31 → 2026-05-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend CHRN 5Y avg Peer Median Verdict
P/E -53.4 · · ·
P/S 39.0 · · ·
P/B (MRQ) 15.5 · · ·
EV / EBITDA 121.9 · · ·
Price / FCF 228.8 · · ·
Price / Cash Flow 71.4 · · ·
EV / Revenue 38.9 · · ·
EV / FCF 228.3 · · ·
Price / Tangible Book 22.2 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -265.8%
Next Report Oct 26, 2026
PeriodReportEPS ActualEPS EstSurprise
March 31, 2026 $-2.04 $-0.23 -769.6%
Dec. 31, 2025 $-1.33 $-0.29 -357.5%
Sept. 30, 2025 $-0.54 $-1.17 53.8%
June 30, 2025 $-1.24 $-1.38 9.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 14
Metric Trend 20262025
Revenue $72M$84M
Cost of Revenue $89M$115M
SG&A Expense $20M$25M
Operating Expenses $109M$140M
Operating Income $-37M$-55M
Other Non-op $-8.0K$0
Pretax Income $-49M$-73M
Income Tax $0$0
Net Income $-50M$-73M
EPS (Basic) $-0.36$-0.53
EPS (Diluted) $-0.36$-0.53
Shares (Basic) 138,698,000138,217,000
Shares (Diluted) 138,698,000138,217,000
EBITDA $23M·
Balance Sheet 23
Metric Trend 20262025
Cash & Equivalents $10M$2M
Receivables $13M$4M
Prepaid Expense $2M$223.0K
Current Assets $44M$6M
PP&E (Net) $32M$11M
PP&E (Gross) $40M$14M
Accum. Depreciation $8M$3M
Goodwill $55M$0
Other Non-current Assets $520.0K$0
Total Assets $326M$304M
Accounts Payable $9M$4M
Accrued Liabilities $4M$572.0K
Current Liabilities $87M$158M
Capital Leases $40M$58M
Total Liabilities $144M$228M
Long-term Debt $4M$12M
Total Debt $4M·
Common Stock $145.0K$138.0K
Paid-in Capital $379M$225M
Retained Earnings $-199M$-149M
Stockholders' Equity $180M$76M
Liabilities + Equity $326M$304M
Shares Outstanding 145,212,000138,217,000
Cash Flow 11
Metric Trend 20262025
D&A $60M$81M
Stock-based Comp $1M$-1M
Other Non-cash $28M·
Operating Cash Flow $39M$-7M
CapEx $27M$1M
Investing Cash Flow $-25M$-1M
Stock Issued $16M$0
Net Stock Activity $16M·
Financing Cash Flow $-7M$11M
Net Change in Cash $7M$2M
Free Cash Flow $12M·
Profitability 7
Metric Trend 20262025
Operating Margin -52.4%·
Net Margin -70.3%·
Pretax Margin -68.8%·
EBITDA Margin 31.9%·
ROA -29.1%·
ROE -53.2%·
ROIC -20.4%·
Liquidity & Solvency 4
Metric Trend 20262025
Current Ratio 0.5·
Quick Ratio 0.3·
Debt / Equity 0.0·
LT Debt / Equity 0.0·
Efficiency 2
Metric Trend 20262025
Asset Turnover 0.4·
Receivables Turnover 7.2·
Per Share 5
Metric Trend 20262025
Book Value / Share $1.24·
Revenue / Share $0.52·
Cash Flow / Share $0.28·
Cash / Share $0.07·
EPS (TTM) $-0.36·
Growth Rates 1
Metric Trend 20262025
Revenue YoY -15.1%·
Valuation (TTM) 14
Metric Trend 20262025
Revenue TTM $72M·
Net Income TTM $-50M·
Market Cap $2.67B·
Enterprise Value $2.66B·
P/E -51.0·
P/S 37.2·
P/B 14.8·
P / Tangible Book 21.2·
P / Cash Flow 68.2·
P / FCF 218.7·
EV / EBITDA 116.5·
EV / FCF 218.2·
EV / Revenue 37.2·
Earnings Yield -2.0%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2026-05-312025-05-31
Revenue $72M $84M
Operating Margin % -52.4% ·
Net Income $-50M $-73M
Diluted EPS $-0.36 $-0.53

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Puissance Cross-Border Opportunities II LLC (2), Puissance Capital Fund (GP) LLC (2), Puissance Capital Management LP (2), Puissance Capital Management (GP) LLC (2), Theodore Wang (2) ×6 filings Nov. 12, 2020 · Initial filing Passive investment SEC
CNI Commercial LLC, Chickasaw Nation Industries, Inc., David Nimmo ×2 filings Aug. 23, 2016 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 33 insiders · 13 officers · 22 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Ying Cenly Chen Chief Executive Officer July 13, 2026 A 2,800,000 0 0 $0
Jack Peurach President & CEO Aug. 31, 2021 A 146,142 0 0 $0
Tom Looby President & CEO Sept. 8, 2017 P 20,315 0 0 $0
Jerome Wong Chief Financial Officer Aug. 16, 2026 A 364,771 1 2 $-44,501
John Glenn Chief Financial Officer March 22, 2022 S 35,130 0 0 $0
Max Scheder-Bieschin Chief Financial Officer May 10, 2018 M 76,959 0 0 $0
Russ Angold President, EksoWorks March 23, 2018 F 397,669 0 0 $0
Jason C Jones Chief Operating Officer March 16, 2026 P 4,449 1 3 $-44,649
Russ Delonzor Chief Operating Officer July 13, 2018 A 16,512 0 0 $0
Rajasekar Jegannathan Chief Technology Officer July 22, 2026 A 1,402,587 0 0 $0
Steven Sherman Executive Chair June 8, 2023 A 449,153 0 0 $0
William R Shaw Chief Commercial Officer Feb. 17, 2022 A 96,943 0 0 $0
Gregory Davault Vice Pres., Global Marketing March 23, 2018 F 17,235 0 0 $0
Andrew Cordell Schaap Director June 29, 2026 A 200,000 0 0 $0
Scott G. Davis Director May 14, 2026 A 188,134 0 1 $-111,912
Ella G. Benson Director May 14, 2026 A 200,000 0 0 $0
Wesley Cummins Director May 14, 2026 A 200,000 0 0 $0
William M Clancy Director May 14, 2026 A 200,000 0 0 $0
Douglas S Miller Director May 14, 2026 A 200,000 0 0 $0
Richard N Nottenburg Director May 14, 2026 A 200,000 0 0 $0
Deborah Lafer Scher Director May 16, 2025 A 314,419 0 0 $0
Kecheng Li Director May 16, 2025 A 460,940 0 0 $0
Corinna Lathan Director May 16, 2025 A 462,409 0 0 $0
Mary Ann Cloyd Director May 16, 2025 A 456,707 0 0 $0
Rhonda A. Wallen Director June 8, 2023 A 142,288 0 0 $0
Stanley Stern Director Dec. 4, 2022 A 167,008 0 0 $0
Theodore T Wang Director Nov. 10, 2020 J 29,828 0 0 $0
Marilyn Hamilton Director July 23, 2020 A 10,770 0 0 $0
Thomas A Schreck Director July 23, 2020 A 9,698 0 0 $0
Amy Mcbride Wendell Director Sept. 14, 2017 P 16,264 0 0 $0
Daniel Boren Director Aug. 31, 2017 X 9,492 0 0 $0
PALEFSKY HOWARD D Director July 5, 2017 A · 0 0 $0
Daniel Asher · Feb. 19, 2026 P 270,432 10 0 $1,172,602

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 2 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.01% 10,042 SH Sept. 10, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 37,583 SH Aug. 19, 2026 Daily

CHRN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 8 analysts BUY
Median target $32.00 +66.6%
2 25.0% Strong Buy
4 50.0% Buy
2 25.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

1 analysts · 2026-09-29

Mean target $32.00 +66.6%

Low$32.00 Mean$32.00 High$32.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CHRN $2.67B -51.0 -15.1% -70.3% -53.2% ·
NVST $3.56B 77.5 8.3% 1.7% 1.5% 54.7%
IRTC $5.73B -127.7 26.2% -6.0% -34.8% 70.6%
PLSE · · · · · ·
ASST · -0.1 1217.5% · · ·
TMDX $4.17B 25.0 37.1% 31.4% 48.1% 59.9%
ATRC $1.97B -164.8 14.9% -2.1% -2.4% 75.0%
BFLY · -12.3 19.0% -79.0% -35.9% 46.9%
AXGN $1.54B -96.3 20.2% -7.0% -13.0% 74.3%
INSP $2.64B 18.9 13.6% 16.0% 19.9% 85.4%
LMAT $1.85B 32.2 13.5% 23.1% 15.3% 71.5%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-K filed Aug 19, 2026